Skip to content

A Prospective Randomized Controlled Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Radical Cystectomy

A Prospective Randomized Controlled Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Radical Cystectomy

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02145871
Enrollment
282
Registered
2014-05-23
Start date
2014-05-21
Completion date
2024-03-14
Last updated
2024-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Cancer

Keywords

Radical Cystectomy, Perioperative Fluid Management, EV1000, 14-069

Brief summary

The purpose of this study is to help us learn what is the best amount of fluid to give to patients during bladder surgery in order to avoid delayed bowel function after surgery, which could prolong hospital stay.

Interventions

OTHERfluid management guided by the EV1000

Sponsors

Memorial Sloan Kettering Cancer Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults (21 years old or greater) who are able to provide informed consent * Patients who undergo an open, elective radical cystectomy

Exclusion criteria

* Patients with active atrial fibrillation or flutter, since the algorithm is not accurate in case of cardiac arrhythmia * Female patients who are pregnant (female patients of child-bearing potential must have a negative serum pregnancy test ≤ 14 days prior to surgery or 15 to 30 days prior to surgery with a negative urine pregnancy test the morning of surgery) * Presence of ascites, because increased abdominal pressure interferes with EV1000 reading accuracy * BMI \> 45 or \<17, because increased abdominal pressure interferes with EV1000 reading accuracy

Design outcomes

Primary

MeasureTime frameDescription
incidence of postoperative ileus (POI)3 yearsPOI will be defined as intolerance of oral intake by postoperative day 5, or the cessation of diet and/or placement of an NGT for clinical signs or symptoms associated with POI, including one or more of the following: nausea, emesis, abdominal bloating or distension, or excessive burping. Rate of ileus will be compared between the treatment groups using the chi-square test. A 95% confidence interval for the difference in ileus rate will also be reported.

Secondary

MeasureTime frameDescription
complications1 year post operativelyOverall rate of grade 2-5 1-year complications, and rate of grade 2-5 gastrointestinal, pulmonary, renal, hematologic and cardiac complications will also be compared using the chi-square test. Based rate of grade 2-5 gastrointestinal, pulmonary, renal, hematologic and cardiac complications will also be compared using the chi-square test.
compare total volume of fluidthe first 72 hoursgiven intraoperatively and during the first 72 hrs postoperatively

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026